BioTime, Inc. Announces Agreement to Acquire ES Cell International.
Business Wire › April 29, 2010
Linked as:
Extract
BioTime, Inc. Announces Agreement to Acquire ES Cell International.
Acquisition to Accelerate BioTime's Development of Human Stem Cell-Based Therapeutics
ALAMEDA, Calif. -- BioTime, Inc. (NYSE Amex:BTIM), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced that it has agreed to acquire the Singapore-based company ...See the full content of this document
Sponsored links
